-
1
-
-
78650399880
-
Eplerenone in patients with systolic heart failure and mild symptoms
-
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
-
(2011)
N Engl J Med
, vol.364
, pp. 11-21
-
-
Zannad, F.1
McMurray, J.J.2
Krum, H.3
Van Veldhuisen, D.J.4
Swedberg, K.5
Shi, H.6
Vincent, J.7
Pocock, S.J.8
Pitt, B.9
-
2
-
-
84856112414
-
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: Insights from the Eplerenone Post- Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
-
Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F. Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post- Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation. 2012;125:271-279.
-
(2012)
Circulation
, vol.125
, pp. 271-279
-
-
Rossignol, P.1
Cleland, J.G.2
Bhandari, S.3
Tala, S.4
Gustafsson, F.5
Fay, R.6
Lamiral, Z.7
Dobre, D.8
Pitt, B.9
Zannad, F.10
-
3
-
-
33646270387
-
Renal impairment and outcomes in heart failure: Systematic review and meta-analysis
-
Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987-1996.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 1987-1996
-
-
Smith, G.L.1
Lichtman, J.H.2
Bracken, M.B.3
Shlipak, M.G.4
Phillips, C.O.5
Dicapua, P.6
Krumholz, H.M.7
-
4
-
-
34848924327
-
Worsening renal function and prognosis in heart failure: Systematic review and meta-analysis
-
Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599-608.
-
(2007)
J Card Fail
, vol.13
, pp. 599-608
-
-
Damman, K.1
Navis, G.2
Voors, A.A.3
Asselbergs, F.W.4
Smilde, T.D.5
Cleland, J.G.6
Van Veldhuisen, D.J.7
Hillege, H.L.8
-
5
-
-
3442886513
-
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
-
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351:543-551.
-
(2004)
N Engl J Med
, vol.351
, pp. 543-551
-
-
Juurlink, D.N.1
Mamdani, M.M.2
Lee, D.S.3
Kopp, A.4
Austin, P.C.5
Laupacis, A.6
Redelmeier, D.A.7
-
6
-
-
77749292028
-
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors
-
Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5:531-548.
-
Clin J Am Soc Nephrol
, vol.2010
, Issue.5
, pp. 531-548
-
-
Weir, M.R.1
Rolfe, M.2
-
7
-
-
3442888821
-
Managing hyperkalemia caused by inhibitors of the renin- angiotensin-aldosterone system
-
Palmer BF. Managing hyperkalemia caused by inhibitors of the renin- angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592.
-
(2004)
N Engl J Med
, vol.351
, pp. 585-592
-
-
Palmer, B.F.1
-
8
-
-
63849177462
-
American college of cardiology foundation; American Heart Association 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the american college of cardiology foundation
-
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1-e90.
-
(2009)
J Am Coll Cardiol
, vol.53
-
-
Hunt, S.A.1
Abraham, W.T.2
Chin, M.H.3
Feldman, A.M.4
Francis, G.S.5
Ganiats, T.G.6
Jessup, M.7
Konstam, M.A.8
Mancini, D.M.9
Michl, K.10
Oates, J.A.11
Rahko, P.S.12
Silver, M.A.13
Stevenson, L.W.14
Yancy, C.W.15
-
9
-
-
77952962152
-
Rationale and design of the eplerenone in mild patients hospitalization and survival study in heart failure (EMPHASIS-HF)
-
Zannad F, McMurray JJ, Drexler H, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2010;12:617-622.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 617-622
-
-
Zannad, F.1
McMurray, J.J.2
Drexler, H.3
Krum, H.4
Van Veldhuisen, D.J.5
Swedberg, K.6
Shi, H.7
Vincent, J.8
Pitt, B.9
-
10
-
-
1642502319
-
National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
-
(2003)
Ann Intern Med.
, vol.139
, pp. 137-147
-
-
Levey, A.S.1
Coresh, J.2
Balk, E.3
Kausz, A.T.4
Levin, A.5
Steffes, M.W.6
Hogg, R.J.7
Perrone, R.D.8
Lau, J.9
Eknoyan, G.10
-
11
-
-
77954951329
-
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival
-
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265-272.
-
(2010)
Circulation
, vol.122
, pp. 265-272
-
-
Testani, J.M.1
Chen, J.2
McCauley, B.D.3
Kimmel, S.E.4
Shannon, R.P.5
-
12
-
-
84868574835
-
RALES Investigators.Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: Insights from RALES (Randomized Aldactone Evaluation Study)
-
Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD; RALES Investigators. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol. 2012;60:2082-2089.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 2082-2089
-
-
Vardeny, O.1
Wu, D.H.2
Desai, A.3
Rossignol, P.4
Zannad, F.5
Pitt, B.6
Solomon, S.D.7
-
13
-
-
84885842429
-
2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810-1852.
-
(2013)
Circulation
, vol.128
, pp. 1810-1852
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
Butler, J.4
Casey Jr., D.E.5
Drazner, M.H.6
Fonarow, G.C.7
Geraci, S.A.8
Horwich, T.9
Januzzi, J.L.10
Johnson, M.R.11
Kasper, E.K.12
Levy, W.C.13
Masoudi, F.A.14
McBride, P.E.15
McMurray, J.J.16
Mitchell, J.E.17
Peterson, P.N.18
Riegel, B.19
Sam, F.20
Stevenson, L.W.21
Tang, W.H.22
Tsai, E.J.23
Wilkoff, B.L.24
more..
-
14
-
-
84864477617
-
Task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology; Esc committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
-
The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-869.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Böhm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Køber, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Rønnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
Bax, J.J.27
Baumgartner, H.28
Ceconi, C.29
Dean, V.30
Deaton, C.31
Fagard, R.32
Funck-Brentano, C.33
Hasdai, D.34
Hoes, A.35
Kirchhof, P.36
Knuuti, J.37
Kolh, P.38
McDonagh, T.39
Moulin, C.40
Popescu, B.A.41
Reiner, Z.42
Sechtem, U.43
Sirnes, P.A.44
Tendera, M.45
Torbicki, A.46
Vahanian, A.47
Windecker, S.48
McDonagh, T.49
Sechtem, U.50
Bonet, L.A.51
Avraamides, P.52
Ben Lamin, H.A.53
Brignole, M.54
Coca, A.55
Cowburn, P.56
Dargie, H.57
Elliott, P.58
Flachskampf, F.A.59
Guida, G.F.60
Hardman, S.61
Iung, B.62
Merkely, B.63
Mueller, C.64
Nanas, J.N.65
Nielsen, O.W.66
Orn, S.67
Parissis, J.T.68
Ponikowski, P.69
more..
-
15
-
-
50149119316
-
Changes in kidney function following heart failure treatment: Focus on renin-angiotensin system blockade
-
Blankstein R, Bakris GL. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade. Heart Fail Clin. 2008;4:425-438.
-
(2008)
Heart Fail Clin
, vol.4
, pp. 425-438
-
-
Blankstein, R.1
Bakris, G.L.2
-
16
-
-
33749254268
-
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
-
Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17:2886-2891.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2886-2891
-
-
Jose, P.1
Skali, H.2
Anavekar, N.3
Tomson, C.4
Krumholz, H.M.5
Rouleau, J.L.6
Moye, L.7
Pfeffer, M.A.8
Solomon, S.D.9
-
17
-
-
4544327596
-
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
-
Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-1295.
-
(2004)
N Engl J Med
, vol.351
, pp. 1285-1295
-
-
Anavekar, N.S.1
McMurray, J.J.2
Velazquez, E.J.3
Solomon, S.D.4
Kober, L.5
Rouleau, J.L.6
White, H.D.7
Nordlander, R.8
Maggioni, A.9
Dickstein, K.10
Zelenkofske, S.11
Leimberger, J.D.12
Califf, R.M.13
Pfeffer, M.A.14
-
18
-
-
35748951306
-
CHARM program investigators.incidence and predictors of hyperkalemia in patients with heart failure: An analysis of the CHARM program
-
Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol. 2007;50:1959-1966.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1959-1966
-
-
Desai, A.S.1
Swedberg, K.2
McMurray, J.J.3
Granger, C.B.4
Yusuf, S.5
Young, J.B.6
Dunlap, M.E.7
Solomon, S.D.8
Hainer, J.W.9
Olofsson, B.10
Michelson, E.L.11
Pfeffer, M.A.12
-
19
-
-
55949112567
-
EPHESUS investigators.Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)
-
Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R; EPHESUS Investigators. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2008;118:1643-1650.
-
(2008)
Circulation
, vol.118
, pp. 1643-1650
-
-
Pitt, B.1
Bakris, G.2
Ruilope, L.M.3
Dicarlo, L.4
Mukherjee, R.5
-
20
-
-
84886023778
-
EMPHASISHF investigators.safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: Analyses of the emphasis-hf study subgroups (Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure)
-
Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASISHF Investigators. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). J Am Coll Cardiol. 2013;62:1585-1593.
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 1585-1593
-
-
Eschalier, R.1
McMurray, J.J.2
Swedberg, K.3
Van Veldhuisen, D.J.4
Krum, H.5
Pocock, S.J.6
Shi, H.7
Vincent, J.8
Rossignol, P.9
Zannad, F.10
Pitt, B.11
-
21
-
-
33749631914
-
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction
-
Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572-1580.
-
(2006)
Circulation
, vol.114
, pp. 1572-1580
-
-
Smilde, T.D.1
Van Veldhuisen, D.J.2
Navis, G.3
Voors, A.A.4
Hillege, H.L.5
|